FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Expires:December 31, 2014
Estimated average burden
hours per response0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
BAKER DOUGLAS P

(Last)(First)(Middle)
3006 LONGHORN BLVD., SUITE 107

(Street)
AUSTINTX78758

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
Applied Nanotech Holdings, Inc [APNT]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Former CFO
3. Date of Earliest Transaction (Month/Day/Year)
03/15/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock         100,000 D  

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option-Rt to Buy (1)        (1) (1) Common Stock 786,100   786,100 D  
8% Convertible Note Payable $ 0.25        (2)03/15/2014 Common Stock 529,228   529,228 D  
Convertible note $ 0.05        (3)12/31/2014 Common Stock 1,500,000   1,500,000 D  
Restricted Stock Grant $ 0        (4) (4) Common Stock 3,289,580   3,289,580 D  
Explanation of Responses:
1. Exercisable currently, at various prices from $0.23 to $2.17, expiring at various dates through 2022.
2. Demand note bearing interest at 8% per year and convertible into common stock at a rate of $0.25 per share at any time.
3. $75,000 note, bearing interest at the lowest rate allowed by the Internal Revenue Service. The Company, at its option, may pay the note by issuing 1.5 million shares of common stock at any time after a shareholder meeting is held to increase the authorized shares, or approve the Nanofilm merger. Until such time, the Company has no ability to pay the note using shares.
4. Restricted stock grant in connection with termination of employment. Shares are issuable as follows: 1.2 million on 9/1/14. 1.2 million six months after completion of Nanofilm Merger. Remaining balance due 1/15/15. Until such time as the Company has a shareholder meeting to increase its authorized shares, or approve the Nanofilm merger, the Company has no ability to fulfill its obligations and issue these shares.
/s/ Douglas P Baker08/05/2014
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.